The Holy Grail of volume resuscitation in the septic patient is. . .

Critical Care Medicine

Volumn 34, Issue 1, 2006, Pages 248-251

  Boldt, Joachim ^a  

^a Anesthesia and Intensive Care   (Germany)

Author keywords

Acute heart failure; Inflammation; Myocardial dysfunction

Indexed keywords

ACUTE HEART FAILURE; EDITORIAL; EVIDENCE BASED PRACTICE; FLUID THERAPY; HEART VENTRICLE FAILURE; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SEPSIS;

EID: 29744463133     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000190897.86123.22     Document Type: Editorial

References (29)

1. Fernandez CJ Jr: One more piece in the septic myocardial depression puzzle? Crit Care Med 2005; 33:690-691
2. Rossi MA, Santos CS: Sepsis-related microvascular myocardial damage with giant cell inflammation and calcification. Virchows Arch 2003; 443:87-92
3. Chagon F, Bentourkia M, Lecomte R, et al: Endotoxin-induced heart dysfunction in rats: Assessment of myocardial perfusion and permeability and the role of fluid resuscitation. Crit Care Med 2006; 34:127-133
4. Hoffmann JN, Vollmar B, Laschke MW, et al: Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 2002; 97:460-470
5. Schell RM, Cole DJ, Schultz RL, et al: Temporary cerebral ischemia. Effects of pentastarch or albumin on reperfusion injury. Anesthesiology 1992; 77:86-92
6. Tian J, Lin X, Guan R, et al: The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004; 98:768-774
7. Kaplan SS, Park TS, Gonzales ER, et al: Hydroxyethyl starch reduces leukocyte adherence and vascular injury in the newborn pig cerebral circulation after asphyxia. Stroke 2000; 31:2218-2223
8. Yeh T Jr, Parmar JM, Rebeyka IM, et al: Limiting edema in neonatal cardiopulmonary bypass with narrow-range molecular weight hydroxyethyl starch. J Thorac Cardiovasc Surg 1992; 104:659-665
9. Hakaim AG, Corsetti R, Cho SI: The pentafraction of hydroxyethyl starch inhibits ischemia-induced compartment syndrome. J Trauma 1994; 37:18-21
10. Sibbald WJ. Blood substitutes - Effects of microcirculation. In: Tissue Oxygenation in Acute Medicine. Sibbald WJ, Messmer K, Fink MP (Eds). Berlin, Heidelberg, Springer, 1998, pp 318-331
11. Perret C, Feihl F: Volume expansion during septic shock. Bull Acad Natl Med 2000; 184:1621-1629
12. Funk W, Baldinger V: Microcirculatory perfusion during volume therapy. Anesthesiology 1995; 82:975-982
13. Wang P, Hauptman JG, Chaudry IH: Hemorrhage produces depression in microvascular blood flow which persists despite fluid resuscitation. Circ Shock 1990; 32:307-318
14. Lagoa CE, de Figueiredo LF, Cruzjr RJ, et al: Effects of volume resuscitation on splanchnic perfusion in canine model of severe sepsis induced by live Escherichia coli infusion. Crit Care 2003; 8:R221-R228
15. Zikria BA, Subbarao C, Oz MC, et al: Hydroxyethyl starch macromolecules reduce myocardial reperfusion injury. Arch Surg 1990; 125:930-934
16. Morisaki H, Bloos F, Keys J, et al: Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 1994; 77:1507-1518
17. Marx G, Cobas Meyer M, Schuerholz T, et al: Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med 2002; 28:629-635
18. Lang K, Boldt J, Suttner S, et al: Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Analg 2001; 93:405-409
19. Yu P, Boughner DR, Sibbald WJ, et al: Myocardial collagen changes and edema in rats with hyperdynamic sepsis. Crit Care Med 1997; 25:657-662
20. Marik PE, Varon J: Sepsis: State of the art. Dis Mon 2001; 47:465-532
21. Marx G: Fluid therapy in sepsis with capillary leakage. Eur J Anaesthesiol 2003; 20:429-442
22. American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med 2004; 170:1247-1259
23. Marik PE, Iglesias J. Would the colloid detractors please sit down. Crit Care Med 2000; 28:2652-2654
24. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-555
25. Schortgen F, Deye N, Brochard L: CRYCO Study Group. Preferred plasma volume expanders for critically ill patients: Results of an international survey. Intensive Care Med 2004; 30:2222-2229
26. Webb AR: Crystalloid or colloid resuscitation. Are we any wiser? Crit Care 1999; 3:R25-R28
27. Finfer S, Bellomo R, Boyce N, et al: SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256
28. Traylor RJ, Pearl RG: Crystalloid versus colloid versus colloid: All colloids are not created equal. Anesth Analg 1996; 83:209-212
29. Pope French G, Longenecker DE (Eds). Fluid Resuscitation. State of the Science of Treating Combat Casualties and Civilian Injuries. Washington, DC, National Academy Press, 1999